Steven Maron, MD, MSc, discusses the role of PD-1 inhibition in esophagogastric cancer.
Steven Maron, MD, MSS
Advertisement
Articles by Steven Maron, MD, MSS
Steven Maron, MD, MSc, discusses sequencing considerations in the frontline treatment of gastrointestinal cancers.
Steven Maron, MD, MSc, discusses HER2-positive tumors in esophageal gastric cancers.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5